Freeline Therapeutics Holdings plc

MORGAN STANLEY

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

189,503

Value ($000)

86

Weight

0.0%

2020 Q3 - 2023 Q1 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	86	0.0%	189,503	3/31/2023
2022 Q4	2/14/2023	91	0.0%	191,403	12/31/2022
2022 Q3	11/14/2022	121	0.0%	173,145	9/30/2022
2022 Q2	10/27/2022	168	0.0%	192,943	6/30/2022
2022 Q1	10/27/2022	207	0.0%	184,730	3/31/2022
2021 Q4	2/14/2022	211	0.0%	106,525	12/31/2021
2021 Q3	11/15/2021	141	0.0%	41,341	9/30/2021
2021 Q2	8/23/2021	274	0.0%	33,637	6/30/2021
2021 Q1	5/17/2021	275	0.0%	22,323	3/31/2021
2020 Q4	2/16/2021	490	0.0%	26,859	12/31/2020
2020 Q3	11/13/2020	206	0.0%	13,206	9/30/2020